Multiple Sclerosis - Oct 3, 2018 Edition :: Medical News | Medical Articles

Medical News | Medical Articles

October 3, 2018     Multiple Sclerosis     The latest multiple sclerosis news from News Medical

Lymphatic vessels surrounding the brain play crucial role in multiple sclerosis, research suggests   Lymphatic vessels that clean the brain of harmful material play a crucial role in the development and progression of multiple sclerosis, new research from the University of Virginia School of Medicine suggests.

Researchers discover key aspect in pathogenesis of multiple sclerosis   A team of researchers the University of Zurich and the University Hospital Zurich has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain.         Cognitive Impairment and Multiple Sclerosis   Multiple sclerosis (MS) is a progressive condition in which the immune system mistakes myelin, the substance responsible for protecting the nerve fibers in the central nervous system, for a foreign body.

Older individuals with multiple sclerosis report higher quality of life than younger counterparts   A recent brief report by MS researchers provides preliminary evidence that older individuals with multiple sclerosis report lower levels of depression and higher quality of life than their younger counterparts.       Processing speed important to higher order cognitive function in multiple sclerosis patients   A recent article by Kessler Foundation researchers underscores the importance of processing speed in overall cognitive function in individuals with multiple sclerosis and their performance of everyday life activities.       MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'   The link between smoking and multiple sclerosis (MS) is “clearer than ever”, the MS Society has announced. Not only are people who smoke more likely to develop MS, smoking can also speed up how fast people with MS become disabled.       CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents   Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.       Scientists discover key aspect in the development of multiple sclerosis   In multiple sclerosis, not only the T cells of the immune system, but also its B cells, play an important role.       Researchers discover new subtype of multiple sclerosis   Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis, providing a better understanding of the individualized nature of the disease.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK